ENABLE BIOSCIENCES INC
- SOUTH SAN FRANCISCO, CA 94080-4562
- enablebiosciences.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
ENABLE BIOSCIENCES INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About ENABLE BIOSCIENCES INC
- Headquarters
- SOUTH SAN FRANCISCO, CA 94080-4562
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEID82RA1JMEBA8
- CAGE7FSW3
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 9 awards
- Total awarded
- $9,045,093
- By phase
- SBIR Phase II: 5
- SBIR Phase I: 4
- By agency
- Department of Health and Human Services: 7
- National Science Foundation: 2
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2023: 1
- 2020: 1
- 2019: 2
- 2018: 3
- 2016: 2
Awards (most recent first)
Advancing an accessible, high-throughput and multiplex islet autoantibody test with self-collected capillary dried blood spots for regulatory clearance
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $2,919,236
Jun 1, 2023 – May 31, 2026
Solicitation PA22-176 (2022) · Topic 200
Multiplex food allergy diagnostic based on IgE immunologic markers
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,490,377
Apr 6, 2020 – Mar 31, 2022
Solicitation PA19-272 (2019) · Topic NIAID
Development of An Automated High-Throughput Dried Blood Spot Assay to Facilitate Large Scale Screening for Type 1 Diabetes Risk
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2019 · $1,487,764
Sep 19, 2019 – Jul 31, 2021
- Direct to Phase II
Solicitation PA18-574 (2018) · Topic NIDDK
Early and accurate differential diagnosis of Lyme and other tick-borne diseases by agglutination-PCR
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $225,000
Mar 11, 2019 – Feb 28, 2021
Solicitation PA18-574 (2018) · Topic NIAID
Multiplex food allergy diagnostic based on IgE immunologic markers
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $223,806
Aug 8, 2018 – Jan 31, 2020
Solicitation PA17-302 (2017) · Topic R
An Ultrasensitive, High-Throughput, and Low-Cost Autoimmunity Panel for the Early Diagnosis and Improved Treatment of Type 1 Diabetes
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $1,499,676
Apr 20, 2018 – Mar 31, 2021
Solicitation PA17-302 (2017) · Topic 200
SBIR Phase II: Development of an ultrasensitive, high-throughput autoantibody discovery platform using agglutination-PCR
SBIR Phase II · National Science Foundation · 2018 · $750,000
Mar 1, 2018 – Feb 29, 2020
Solicitation year 2016 · Topic BT
Antibody-Detection-by-Agglutination-PCR (ADAP): An Ultra-Sensitive, High-Throughput, Multiplexable Tool for T1D Diagnosis and Monitoring
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $224,423
Aug 1, 2016 – Sep 30, 2017
Solicitation DK15-024 (2016) · Topic 200
SBIR Phase I: Development of an ultrasensitive, high-throughput autoantibody discovery platform using agglutination-PCR
SBIR Phase I · National Science Foundation · 2016 · $224,811
Jul 1, 2016 – Dec 31, 2016
Solicitation year 2015 · Topic BM
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325413Title not in the curated listPrimarySmall business under this code’s size standard
- 334516Analytical Laboratory Instrument ManufacturingSmall business under this code’s size standard
- 541713Research and Development in NanotechnologySmall business under this code’s size standard
SAM.gov reports this entity as small under 3 of 3 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
- 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- AJ13GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT
- Q301REFERENCE LABORATORY TESTING
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with ENABLE BIOSCIENCES INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
